Skip to main content
Top
Published in: Inflammation 6/2015

01-12-2015

Anti-Citrullinated Protein Antibodies Induce Macrophage Subset Disequilibrium in RA Patients

Authors: Wei Zhu, Xiu Li, Shaohong Fang, Xiaoli Zhang, Ying Wang, Tongshuai Zhang, Zhaoying Li, Yanwen Xu, Siying Qu, Chuanliang Liu, Fei Gao, Haile Pan, Guangyou Wang, Hulun Li, Bo Sun

Published in: Inflammation | Issue 6/2015

Login to get access

Abstract

We used samples from rheumatoid arthritis (RA) patients to examine whether Anti-citrullinated protein antibodies (ACPAs) alter macrophage subset distribution and promote RA development. Macrophage subset distributions and interferon regulatory factor 4 (IRF4) and IRF5 expressions were analyzed. ACPAs were purified by affinity column. After RA and osteoarthritis (OA) patients’ macrophages were cocultured with ACPAs, macrophage subsets and IRF4 and IRF5 expressions were measured. Small interfering RNAs (siRNAs) were transfected into ACPA-activated cells to suppress IRF4 or IRF5. Fluorescence-activated cell sorting (FACS), Western blot, and immunohistochemistry were performed. Macrophage subset disequilibrium occurred in RA patient synovial fluids. IRF4 and IRF5 were all expressed in the synovial fluid and synovium. ACPAs (40 IU/ml) could induce macrophages to polarize to M1 subsets, and the percentage of increased M1/M2 ratio of RA patients was higher than that of the OA patients. ACPAs also induce IRF4 and IRF5 protein expressions. IRF5 siRNA transfection impaired ACPA activity significantly. We demonstrated that macrophage subset disequilibrium occurred in RA patients. ACPAs induced IRF5 activity and led to M1 macrophage polarization.
Literature
1.
go back to reference van Venrooij, W.J., J.J. van Beers, and G.J. Pruijn. 2008. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Annals of the New York Academy of Sciences 1143: 268–285.CrossRefPubMed van Venrooij, W.J., J.J. van Beers, and G.J. Pruijn. 2008. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Annals of the New York Academy of Sciences 1143: 268–285.CrossRefPubMed
2.
go back to reference Nielen, M.M., D. van Schaardenburg, H.W. Reesink, R.J. van de Stadt, I.E. van der Horst-Bruinsma, M.H. de Koning, et al. 2004. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis and Rheumatism 50: 380–386.CrossRefPubMed Nielen, M.M., D. van Schaardenburg, H.W. Reesink, R.J. van de Stadt, I.E. van der Horst-Bruinsma, M.H. de Koning, et al. 2004. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis and Rheumatism 50: 380–386.CrossRefPubMed
3.
go back to reference Rantapaa-Dahlqvist, S., B.A. de Jong, E. Berglin, G. Hallmans, G. Wadell, H. Stenlund, et al. 2003. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis and Rheumatism 48: 2741–2749.CrossRefPubMed Rantapaa-Dahlqvist, S., B.A. de Jong, E. Berglin, G. Hallmans, G. Wadell, H. Stenlund, et al. 2003. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis and Rheumatism 48: 2741–2749.CrossRefPubMed
4.
go back to reference Chibnik, L.B., L.A. Mandl, K.H. Costenbader, P.H. Schur, and E.W. Karlson. 2009. Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. Journal of Rheumatology 36: 706–711.PubMedCentralCrossRefPubMed Chibnik, L.B., L.A. Mandl, K.H. Costenbader, P.H. Schur, and E.W. Karlson. 2009. Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. Journal of Rheumatology 36: 706–711.PubMedCentralCrossRefPubMed
5.
go back to reference Vossenaar, E.R., T.R. Radstake, A. van der Heijden, M.A. van Mansum, C. Dieteren, D.J. de Rooij, et al. 2004. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Annals of the Rheumatic Diseases 63: 373–381.PubMedCentralCrossRefPubMed Vossenaar, E.R., T.R. Radstake, A. van der Heijden, M.A. van Mansum, C. Dieteren, D.J. de Rooij, et al. 2004. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Annals of the Rheumatic Diseases 63: 373–381.PubMedCentralCrossRefPubMed
6.
go back to reference De Rycke, L., A.P. Nicholas, T. Cantaert, E. Kruithof, J.D. Echols, B. Vandekerckhove, et al. 2005. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis and Rheumatism 52: 2323–2330.CrossRefPubMed De Rycke, L., A.P. Nicholas, T. Cantaert, E. Kruithof, J.D. Echols, B. Vandekerckhove, et al. 2005. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis and Rheumatism 52: 2323–2330.CrossRefPubMed
7.
go back to reference Chapuy-Regaud, S., M. Sebbag, D. Baeten, C. Clavel, C. Foulquier, F. De Keyser, et al. 2005. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. Journal of Immunology 174: 5057–5064.CrossRef Chapuy-Regaud, S., M. Sebbag, D. Baeten, C. Clavel, C. Foulquier, F. De Keyser, et al. 2005. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. Journal of Immunology 174: 5057–5064.CrossRef
8.
go back to reference Kinloch, A., K. Lundberg, R. Wait, N. Wegner, N.H. Lim, A.J. Zendman, et al. 2008. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis and Rheumatism 58: 2287–2295.CrossRefPubMed Kinloch, A., K. Lundberg, R. Wait, N. Wegner, N.H. Lim, A.J. Zendman, et al. 2008. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis and Rheumatism 58: 2287–2295.CrossRefPubMed
9.
go back to reference Kuhn, K.A., L. Kulik, B. Tomooka, K.J. Braschler, W.P. Arend, W.H. Robinson, et al. 2006. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. Journal of Clinical Investigation 116: 961–973.PubMedCentralCrossRefPubMed Kuhn, K.A., L. Kulik, B. Tomooka, K.J. Braschler, W.P. Arend, W.H. Robinson, et al. 2006. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. Journal of Clinical Investigation 116: 961–973.PubMedCentralCrossRefPubMed
10.
go back to reference Berglin, E., T. Johansson, U. Sundin, E. Jidell, G. Wadell, G. Hallmans, et al. 2006. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Annals of the Rheumatic Diseases 65: 453–458.PubMedCentralCrossRefPubMed Berglin, E., T. Johansson, U. Sundin, E. Jidell, G. Wadell, G. Hallmans, et al. 2006. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Annals of the Rheumatic Diseases 65: 453–458.PubMedCentralCrossRefPubMed
11.
go back to reference del Val del Amo, N., R. Ibanez Bosch, C. Fito Manteca, R. Gutierrez Polo, and E. Loza Cortina. 2006. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clinical and Experimental Rheumatology 24: 281–286.PubMed del Val del Amo, N., R. Ibanez Bosch, C. Fito Manteca, R. Gutierrez Polo, and E. Loza Cortina. 2006. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clinical and Experimental Rheumatology 24: 281–286.PubMed
12.
go back to reference Clavel, C., L. Nogueira, L. Laurent, C. Iobagiu, C. Vincent, M. Sebbag, et al. 2008. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis and Rheumatism 58: 678–688.CrossRefPubMed Clavel, C., L. Nogueira, L. Laurent, C. Iobagiu, C. Vincent, M. Sebbag, et al. 2008. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis and Rheumatism 58: 678–688.CrossRefPubMed
13.
go back to reference Lu, M.C., N.S. Lai, H.C. Yu, H.B. Huang, S.C. Hsieh, and C.L. Yu. 2010. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis and Rheumatism 62: 1213–1223.CrossRefPubMed Lu, M.C., N.S. Lai, H.C. Yu, H.B. Huang, S.C. Hsieh, and C.L. Yu. 2010. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis and Rheumatism 62: 1213–1223.CrossRefPubMed
14.
go back to reference Lu, M.C., N.S. Lai, W.Y. Yin, H.C. Yu, H.B. Huang, C.H. Tung, et al. 2013. Anti-citrullinated protein antibodies activated ERK1/2 and JNK mitogen-activated protein kinases via binding to surface-expressed citrullinated GRP78 on mononuclear cells. Journal of Clinical Immunology 33: 558–566.CrossRefPubMed Lu, M.C., N.S. Lai, W.Y. Yin, H.C. Yu, H.B. Huang, C.H. Tung, et al. 2013. Anti-citrullinated protein antibodies activated ERK1/2 and JNK mitogen-activated protein kinases via binding to surface-expressed citrullinated GRP78 on mononuclear cells. Journal of Clinical Immunology 33: 558–566.CrossRefPubMed
15.
go back to reference Li, J., H.C. Hsu, and J.D. Mountz. 2012. Managing macrophages in rheumatoid arthritis by reform or removal. Current Rheumatology Reports 14: 445–454.PubMedCentralCrossRefPubMed Li, J., H.C. Hsu, and J.D. Mountz. 2012. Managing macrophages in rheumatoid arthritis by reform or removal. Current Rheumatology Reports 14: 445–454.PubMedCentralCrossRefPubMed
16.
go back to reference Biswas, S.K., M. Chittezhath, I.N. Shalova, and J.Y. Lim. 2012. Macrophage polarization and plasticity in health and disease. Immunologic Research 53: 11–24.CrossRefPubMed Biswas, S.K., M. Chittezhath, I.N. Shalova, and J.Y. Lim. 2012. Macrophage polarization and plasticity in health and disease. Immunologic Research 53: 11–24.CrossRefPubMed
17.
go back to reference Zhu, W., J. Yu, Y. Nie, X. Shi, Y. Liu, F. Li, et al. 2014. Disequilibrium of m1 and m2 macrophages correlates with the development of experimental inflammatory bowel diseases. Immunological Investigations 43: 638–652.CrossRefPubMed Zhu, W., J. Yu, Y. Nie, X. Shi, Y. Liu, F. Li, et al. 2014. Disequilibrium of m1 and m2 macrophages correlates with the development of experimental inflammatory bowel diseases. Immunological Investigations 43: 638–652.CrossRefPubMed
18.
go back to reference Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.CrossRefPubMed Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.CrossRefPubMed
19.
go back to reference Schellekens, G.A., H. Visser, B.A. de Jong, F.H. van den Hoogen, J.M. Hazes, F.C. Breedveld, et al. 2000. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis and Rheumatism 43: 155–163.CrossRefPubMed Schellekens, G.A., H. Visser, B.A. de Jong, F.H. van den Hoogen, J.M. Hazes, F.C. Breedveld, et al. 2000. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis and Rheumatism 43: 155–163.CrossRefPubMed
20.
go back to reference Savitsky, D., T. Tamura, H. Yanai, and T. Taniguchi. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunology, Immunotherapy 59: 489–510.CrossRefPubMed Savitsky, D., T. Tamura, H. Yanai, and T. Taniguchi. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunology, Immunotherapy 59: 489–510.CrossRefPubMed
21.
go back to reference Krausgruber, T., K. Blazek, T. Smallie, S. Alzabin, H. Lockstone, N. Sahgal, et al. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 12: 231–238.CrossRefPubMed Krausgruber, T., K. Blazek, T. Smallie, S. Alzabin, H. Lockstone, N. Sahgal, et al. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 12: 231–238.CrossRefPubMed
22.
go back to reference Takaoka, A., H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243–249.CrossRefPubMed Takaoka, A., H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243–249.CrossRefPubMed
23.
go back to reference Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunology 11: 936–944.CrossRefPubMed Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunology 11: 936–944.CrossRefPubMed
24.
go back to reference Wang, T., X. Sun, J. Zhao, J. Zhang, H. Zhu, C. Li, et al. 2014. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2013-204228. Wang, T., X. Sun, J. Zhao, J. Zhang, H. Zhu, C. Li, et al. 2014. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Annals of the Rheumatic Diseases. doi:10.​1136/​annrheumdis-2013-204228.
25.
go back to reference Jiao, Z., W. Wang, S. Hua, M. Liu, H. Wang, X. Wang, et al. 2014. Blockade of Notch signaling ameliorates murine collagen-induced arthritis via suppressing Th1 and Th17 cell responses. American Journal of Pathology 184: 1085–1093.CrossRefPubMed Jiao, Z., W. Wang, S. Hua, M. Liu, H. Wang, X. Wang, et al. 2014. Blockade of Notch signaling ameliorates murine collagen-induced arthritis via suppressing Th1 and Th17 cell responses. American Journal of Pathology 184: 1085–1093.CrossRefPubMed
26.
go back to reference Moreland, L.W., P.W. Pratt, M.D. Mayes, A. Postlethwaite, M.H. Weisman, T. Schnitzer, et al. 1995. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis and Rheumatism 38: 1581–1588.CrossRefPubMed Moreland, L.W., P.W. Pratt, M.D. Mayes, A. Postlethwaite, M.H. Weisman, T. Schnitzer, et al. 1995. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis and Rheumatism 38: 1581–1588.CrossRefPubMed
27.
go back to reference Maruotti, N., F.P. Cantatore, E. Crivellato, A. Vacca, and D. Ribatti. 2007. Macrophages in rheumatoid arthritis. Histology and Histopathology 22: 581–586.PubMed Maruotti, N., F.P. Cantatore, E. Crivellato, A. Vacca, and D. Ribatti. 2007. Macrophages in rheumatoid arthritis. Histology and Histopathology 22: 581–586.PubMed
28.
go back to reference Li, J., H.C. Hsu, P. Yang, Q. Wu, H. Li, L.E. Edgington, et al. 2012. Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model. Arthritis and Rheumatism 64: 1098–1109.PubMedCentralCrossRefPubMed Li, J., H.C. Hsu, P. Yang, Q. Wu, H. Li, L.E. Edgington, et al. 2012. Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model. Arthritis and Rheumatism 64: 1098–1109.PubMedCentralCrossRefPubMed
29.
go back to reference Weiss, M., K. Blazek, A.J. Byrne, D.P. Perocheau, and I.A. Udalova. 2013. IRF5 is a specific marker of inflammatory macrophages in vivo. Mediators of Inflammation 2013: 245804.PubMedCentralCrossRefPubMed Weiss, M., K. Blazek, A.J. Byrne, D.P. Perocheau, and I.A. Udalova. 2013. IRF5 is a specific marker of inflammatory macrophages in vivo. Mediators of Inflammation 2013: 245804.PubMedCentralCrossRefPubMed
30.
go back to reference Snir, O., M. Widhe, C. von Spee, J. Lindberg, L. Padyukov, K. Lundberg, et al. 2009. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Annals of the Rheumatic Diseases 68: 736–743.CrossRefPubMed Snir, O., M. Widhe, C. von Spee, J. Lindberg, L. Padyukov, K. Lundberg, et al. 2009. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Annals of the Rheumatic Diseases 68: 736–743.CrossRefPubMed
31.
go back to reference Kokkonen, H., M. Johansson, L. Innala, E. Jidell, and S. Rantapaa-Dahlqvist. 2007. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Research and Therapy 9: R56.PubMedCentralCrossRefPubMed Kokkonen, H., M. Johansson, L. Innala, E. Jidell, and S. Rantapaa-Dahlqvist. 2007. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Research and Therapy 9: R56.PubMedCentralCrossRefPubMed
32.
go back to reference Yoo, S.A., S. You, H.J. Yoon, D.H. Kim, H.S. Kim, K. Lee, et al. 2012. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. Journal of Experimental Medicine 209: 871–886.PubMedCentralCrossRefPubMed Yoo, S.A., S. You, H.J. Yoon, D.H. Kim, H.S. Kim, K. Lee, et al. 2012. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. Journal of Experimental Medicine 209: 871–886.PubMedCentralCrossRefPubMed
Metadata
Title
Anti-Citrullinated Protein Antibodies Induce Macrophage Subset Disequilibrium in RA Patients
Authors
Wei Zhu
Xiu Li
Shaohong Fang
Xiaoli Zhang
Ying Wang
Tongshuai Zhang
Zhaoying Li
Yanwen Xu
Siying Qu
Chuanliang Liu
Fei Gao
Haile Pan
Guangyou Wang
Hulun Li
Bo Sun
Publication date
01-12-2015
Publisher
Springer US
Published in
Inflammation / Issue 6/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-015-0188-z

Other articles of this Issue 6/2015

Inflammation 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine